发明授权
EP2646432B1 SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
有权
代入为BENZOPYRAZINDERIVATE FGFR激酶抑制剂用于癌症治疗
- 专利标题： SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
- 专利标题（中）： 代入为BENZOPYRAZINDERIVATE FGFR激酶抑制剂用于癌症治疗
-
申请号： EP11805567.2申请日： 2011-11-29
-
公开(公告)号： EP2646432B1公开(公告)日： 2015-04-08
- 发明人: BERDINI, Valerio , SAXTY, Gordon , MURRAY, Christopher William , BESONG, Gilbert Ebai , HAMLETT, Christopher Charles Frederick , WOODHEAD, Steven John , LIGNY, Yannick Aimé Eddy , ANGIBAUD, Patrick René
- 申请人： Astex Therapeutics Limited
- 申请人地址： 436 Cambridge Science Park Milton Park Cambridge Cambridgeshire CB4 0QA GB
- 专利权人： Astex Therapeutics Limited
- 当前专利权人： Astex Therapeutics Limited
- 当前专利权人地址： 436 Cambridge Science Park Milton Park Cambridge Cambridgeshire CB4 0QA GB
- 代理机构： Trueman, Lucy Petra
- 优先权： GB201020179 20101129; US417744P 20101129
- 国际公布： WO2012073017 20120607
- 主分类号： C07D403/04
- IPC分类号： C07D403/04 ; A61K31/502 ; A61P35/00
摘要：
The invention relates to new quinoxaline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
公开/授权文献
信息查询
